Allergen specific immunotherapy – this is the only treatment so far that can modify the natural course of the respiratory allergy, as well as its causes. The main objective of this therapy - to reduce the person's sensitivity to the allergen (-s), while replacing the immune response and ensuring the tolerance for the allergen (-s).
The clinical tests and studies that have been carried out over the years, as well as meta-analysis of the received data, have proved that patients to whom this therapy is practiced, can achieve the desired results: to improve the quality of life, to reduce the long-term costs regarding the reduced or disappeared necessity to use the medication lowering the allergy symptoms as well as to change the course of allergic disease.
Allergen specific immunotherapy not only reduces the symptoms (during the treatment) but also has the long term effects after the termination of the treatment. Moreover, it prevents the progression of allergic diseases such as the transition of the allergic rhinitis to bronchial asthma.
Allergic diseases that may be treated by allergen specific immunotherapy:
– Allergic rhinitis with or without conjunctivitis, including other diseases: seasonal allergic rhinitis/conjunctivitis; persistent allergic rhinitis/conjunctivitis; seasonal + persistent allergic rhinitis/conjunctivitis.
–Allergic asthma: seasonal allergic asthma; persistent allergic asthma.
– Allergic rhinitis + allergic asthma.
The course of treatment with allergen specific immunotherapy:
– The patient is administered with the allergen in small quantities
– The doses are increased gradually until the body gets used to the allergen, and the immune system begins to ignore it, i.e. the cause of the disease is influenced
– Optimal period of treatment – 3 years.
Immunotherapy restores the balance of the immune system by reducing the production of immunoglobulin E. It accustoms the body to the allergen. In order for the doctor to be able to target the allergen specific immunotherapy, a patient's sensitivity to the founded allergens must be tested to the molecular level. For example, if the skin prick test or the primary blood test for determination of the allergy shows that the patient is allergic to birch and apple, after the testing with the techniques of the molecular diagnostic it may become apparent that the allergy arises only from birch.
During the Allergomedica program, the patient’s sensitivity to the specific allergens is determined, as well as the components of the allergens are examined. In accordance with the received information, the doctor is able to provide the appropriate plan for the control and treatment of allergy.